BUD - Brachytherapy

Quote

Anonymous

Guest
When is Ring & Wieland going to a plug on this business? We consider ourselves market leaders, but we seem to be losing and losing ground everyday. NASI has thrown in the towel - who is left? The only contender I see is BrachySciences, as they provide all 3 isotopes to their customers. It is only a matter of time until Brachy is sold-off.
 






Anonymous said:
When is Ring & Wieland going to a plug on this business? We consider ourselves market leaders, but we seem to be losing and losing ground everyday. NASI has thrown in the towel - who is left? The only contender I see is BrachySciences, as they provide all 3 isotopes to their customers. It is only a matter of time until Brachy is sold-off.
Click to expand...


We are the market leaders. Stop worring about Brachysciences and thier garbage products. Work the plan you putz.
 












This industry is dying a slow death. There are so many competitive treatments that are taking market share. Even though we are market leaders - it doesn't portray a good outlook going forward for the overall industry.
 












Wow...it cost Bard $51 million because Weiland, Mirsky and their merry men (Tony the Queer) went around buying business...

C. R. Bard, Inc. (the "company") announced it has reached a preliminary agreement with the civil and criminal divisions of the United States Attorney's Office for the Northern District of Georgia (USAO) to resolve claims with respect to the previously-disclosed investigation of the company's brachytherapy business. In connection with this preliminary agreement, the company will record a charge of approximately $51 million ($40.8 million after tax) in the fourth quarter of 2011. The ultimate settlement of this matter is subject to the negotiation and execution of definitive agreements, which will likely include civil settlement and non-prosecution agreements, and a corporate integrity agreement with the U.S. Department of Health and Human Services, Office of Inspector General ("OIG"). If the definitive agreements are not finalized, the eventual costs related to this matter could be materially different than this charge and the company cannot give any assurances that this matter will not have a material adverse effect on the company's business, results of operations, financial condition and/or liquidity. See the company's September 30, 2011 Form 10-Q for additional information regarding this matter.
 


















Top Bottom
Back
Quote